Abstract
The nanodiamond (ND) conjugates of gefitinib (GF) and erlotinib (EL) were assembled for in vitro lung cancer treatments. The carboxylate infrared bands along with the negative surface charge of -28.3 (±2.1) mV were found efficient to conjugate the nitrogen-containing quinazoline ring drugs, due to the electrostatic interactions, resulting from the surface changes to -12.0 (±1.2) mV and -9.1 (±1.2) mV after adsorption of GF and EL on NDs, respectively. The physicochemical properties of NDs were characterized by transmission electron microcopy, X-ray diffraction, X-ray photoelectron, infrared and Raman spectroscopic tools. The size distributions of NDs after the self-assembly of GF and EL could be checked by dynamic light scattering measurements. The uptake of NDs in cancer cells was estimated by fluorescence microscopy. Cell viability appeared to decrease by 30-50% at 50 and 100 nM of GF and EL, respectively, after the treatment of PEG-assembled NDs compared to the cases using free drugs. Our ND conjugates may be potentially useful for overcoming the chemoresistances in lung cancer cells.
Similar content being viewed by others
References
Lim, T., Lee, S.Y., Yang, J., Hwang, S.Y. & Ahn, Y. Microfluidic biochips for simple impedimetric detection of thrombin based label-free DNA aptamers. Bio-Chip J. 11, 109–115 (2017).
Pyun, J.-C., Jose, J. & Park, M. Development of a wash-free immunoassay using Escherichia coli cells with autodisplayed Z-domains. Analyst 142, 1720–1728 (2017).
Jeon, H., Lee, M., Jang, W. & Kwon, Y. Intein-mediated protein engineering for biosensor fabrication. Bio-Chip J. 10, 277–287 (2016).
Park, M., Jung, H., Jeong, Y. & Jeong, K.-H. Plasmonic schirmer strip for human tear-based gouty arthritis diagnosis using surface-enhanced Raman scattering, ACS Nano 11, 438–443 (2017).
Lim, D.G. et al. Combinatorial nanodiamond in pharmaceutical and biomedical applications. Int. J. Pharm. 514, 41–51 (2016).
Moore, L. et al. Biocompatibility assessment of detonation nanodiamond in non-human primates and rats using histological, hematologic, and urine analysis. ACS Nano 10, 7385–7400 (2016).
Bertrand, J.R. et al. Plasma hydrogenated cationic detonation nanodiamonds efficiently deliver to human cells in culture functional siRNA targeting the Ewing sarcoma junction oncogene. Biomaterials 45, 93–98 (2015).
Wang, D., Li, Y., Tian, Z., Cao, R. & Yang, B. Transferrin-conjugated nanodiamond as an intracellular transporter of chemotherapeutic drug and targeting therapy for cancer cells. Ther. Deliv. 5, 511–524 (2014).
Lam, R. & Ho, D. Nanodiamonds as vehicles for systemic and localized drug delivery. Expert. Opin. Drug Deliv. 6, 883–895 (2009).
Gibson, N.M., Luo, T.J.M., Shenderova, O., Koscheev, A.P. & Brenner, D.W. Electrostatically mediated adsorption by nanodiamond and nanocarbon particles. J. Nanopart. Res. 14, 700 (2012).
Xiao, J. et al. Nanodiamonds-mediated doxorubicin nuclear delivery to inhibit lung metastasis of breast cancer. Biomaterials 34, 9648–9656 (2013).
Wang, D. et al. PEGylated nanodiamond for chemotherapeutic drug delivery. Diam. Relat. Mater. 36, 26–34 (2013).
Liu, K.K. et al. Covalent linkage of nanodiamond-paclitaxel for drug delivery and cancer therapy. Nanotechnology 21, 315106 (2010).
Solarska-Ściuk, K. et al. Effect of functionalized and non-functionalized nanodiamond on the morphology and activities of antioxidant enzymes of lung epithelial cells (A549). Chem. Biol. Interact. 222, 135–147 (2014).
Chu, H.L. et al. Development of a growth-hormoneconjugated nanodiamond complex for cancer therapy. ChemMedChem 9, 1023–1029 (2014).
Chang, C.C. et al. Laser induced popcornlike conformational transition of nanodiamond as a nanoknife. Appl. Phys. Lett. 93, 033905 (2008).
Kaur, R. & Badea, I. Nanodiamonds as novel nanomaterials for biomedical applications: drug delivery and imaging systems. Int. J. Nanomed. 8, 203–220 (2013).
Zhu, Y. et al. The biocompatibility of nanodiamonds and their application in drug delivery systems. Theranostics 2, 302–312 (2012).
Mochalin, V.N. et al. Adsorption of drugs on nanodiamond: toward development of a drug delivery platform. Mol. Pharm. 10, 3728–3735 (2013).
Brugger, W. & Thomas, M. EGFR-TKI resistant nonsmall cell lung cancer (NSCLC): new developments and implications for future treatment. Lung Cancer 77, 2–8 (2012).
Sharma, S.V., Bell, D.W., Settleman, J. & Haber, D.A. Epidermal growth factor receptor mutations in lung cancer. Nat. Rev. Cancer 7, 169–181 (2007).
Nobili, S., Landini, I., Mazzei, T. & Mini, E. Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression. Med. Res. Rev. 32, 1220–1262 (2012).
Lam, A.T.N. et al. Adsorption and desorption of tyrosine kinase inhibitor erlotinib on gold nanoparticles. J. Colloids Interface Sci. 425, 96–101 (2014).
Lam, A.T.N. et al. Colloidal gold nanoparticle conjugates of gefitinib. Col. Surf. B 123, 61–67 (2014).
Xiao, J. et al. Nanodiamonds-mediated doxorubicin nuclear delivery to inhibit lung metastasis of breast cancer. Biomaterials 34, 9648–9656 (2013).
Li, W.M., Mayer, L.D. & Bally, M.B. Prevention of antibody-mediated elimination of ligand-targeted liposomes by using poly(ethylene glycol)-modified lipids. J. Pharmacol. Exp. Ther. 300, 976–983 (2002).
Varsányi, G. Assignments for vibrational spectra of seven hundred benzene derivatives. Halsted Press Book 1, 27–28 (1974).
Mochalin, V.N., Shenderova, O., Ho, D. & Gogotsi, Y. The properties and applications of nanodiamonds. Nat. Nanotechnol. 7, 11–23 (2012).
Ferrari, A.C. & Robertson, J. Raman spectroscopy of amorphous, nanostructured, diamond-like carbon, and nanodiamond. Phil. Trans. R. Soc. Lond. A 362, 2477–2512 (2004).
Nguyen, T., Tekrony, A., Yaehne, K. & Cramb, D.T. Designing a better theranostic nanocarrier for cancer applications. Nanomedicine 9, 2371–2386 (2014).
Jeong, S. et al. Low-toxicity chitosan gold nanoparticles for small hairpin RNA delivery in human lung adenocarcinoma cells. J. Mater. Chem. 21, 13853–13859 (2011).
Kim, H. et al. Multiscale simulation as a framework for the enhanced design of nanodiamond-polyethylenimine-based gene delivery. J. Phys. Chem. Lett. 3, 3791–3797 (2012).
Fröhlich, E. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int. J. Nanomed. 7, 5577–5591 (2012).
Choi, S.Y. et al. Cellular uptake and cytotoxicity of positively charged chitosan gold nanoparticles in human lung adenocarcinoma cells. J. Nanopart. Res. 14, 1234 (2012).
Reina, G. et al. Rhodamine/nanodiamond as a system model for drug carrier. J. Nanosci. Nanotechnol. 15, 1022–1029 (2015).
Kemnitz, K., Tamai, N., Yamazaki, I., Nakashima, N. & Yoshihara, K. Fluorescence decays and spectral properties of rhodamine B in submono-, mono-, and multilayer systems. J. Phys. Chem. 90, 5094–5101 (1986).
Van der Auweraer, M., Verschuere, B. & De Schryver, F.C. Absorption and fluorescence properties of rhodamine B derivatives forming Langmuir-Blodgett films. Langmuir 4, 583–588 (1988).
Man, H.B. et al. Synthesis of nanodiamond-daunorubicin conjugates to overcome multidrug chemoresistance in leukemia. Nanomedicine 10, 359–369 (2014).
Coldren, C.D. et al. Baseline gene expression predicts sensitivity to gefitinib in non-small cell lung cancer cell lines. Mol. Cancer Res. 4, 521–528 (2006).
Perevedentseva, E. et al. Nanodiamond internalization in cells and the cell uptake mechanism. J. Nanoparticle. Res. 15, 1834 (2013).
Choi, S.Y. et al. In vitro toxicity of serum protein-adsorbed citrate-reduced gold nanoparticles in human lung adenocarcinoma cells. Toxicology In Vitro 26, 229–237 (2012).
Sadauskas, E. et al. Kupffer cells are central in the removal of nanoparticles from the organism. Part. Fibre Toxicol. 4, 10 (2007).
Chol, H.S. et al. Renal clearance of quantum dots. Nat. Biotechnol. 25, 1165–1170 (2007).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lam, A.T.N., Yoon, JH., Ly, N.H. et al. Electrostatically Self-assembled Quinazoline-based Anticancer Drugs on Negatively-charged Nanodiamonds for Overcoming the Chemoresistances in Lung Cancer Cells. BioChip J 12, 163–171 (2018). https://doi.org/10.1007/s13206-017-2209-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13206-017-2209-5